Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Flavonoid glycoside found in Scutellaria.
Synthetic steroid hormone; AR and ER antagonist...
D2 and D4 dopamine receptor inhibitor.
ERK1/2 inhibitor.
Bisphosphonate; FPPS inhibitor.
Triterpenoid
Non-chlorinated analogue of the mycotoxin Ochra...
Coumarin lactone found in chicory and other pla...
Thiamine, coccidiostat; thiamine transporter in...
Endogenous peptide neurotransmitter, involved i...
S-enantiomer of citalopram; SERT inhibitor.
Sulfonamide; folic acid synthesis inhibitor.
Benzophenanthridine alkaloid found in Garcinia....
STING antagonist
Recombinant HIV-1 antigen fragment.
Endogenous peptide, cleavage product of AT II; ...
PAI-1 inhibitor.
Histamine H1-antagonist
Nedd8-activating enzyme inhibitor.
NSAID; COX-2 inhibitor.